Guizhou Yibai Pharmaceutical Co Ltd Cash Flow Conversion Efficiency

Latest as of September 2025: 0.013x

Guizhou Yibai Pharmaceutical Co Ltd cash flow conversion efficiency. Based on the latest financial reports, Guizhou Yibai Pharmaceutical Co Ltd (600594) has a cash flow conversion efficiency ratio of 0.013x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥33.28 Million ≈ $4.87 Million USD) by net assets (CN¥2.52 Billion ≈ $368.09 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Guizhou Yibai Pharmaceutical Co Ltd (2002–2025)

Cash flow conversion efficiency of Guizhou Yibai Pharmaceutical Co Ltd from 2002 to 2025. This chart illustrates how Guizhou Yibai Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View 600594 stock price for real-time trading data and today's change.

Guizhou Yibai Pharmaceutical Co Ltd Cash Flow Conversion Ratio Explained

Guizhou Yibai Pharmaceutical Co Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Guizhou Yibai Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Guizhou Yibai Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency. Also see Guizhou Yibai Pharmaceutical Co Ltd stock valuation for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Mandalay Resources Corp TO:MND	0.109x
Centuria Office REIT AU:COF	0.021x
Zhejiang HISUN Biomaterials Co. Ltd. A SHG:688203	N/A
Husqvarna AB (publ) ST:HUSQ-A	-0.066x
Protec Co. Ltd KQ:053610	0.015x
Cedar Woods Properties Ltd AU:CWP	0.159x
Rieter Holding AG SW:RIEN	-0.126x
Jiangsu Canopus Wisdom Medical Technology Co. Ltd. A SHE:301290	N/A

Annual Cash Flow Conversion Efficiency for Guizhou Yibai Pharmaceutical Co Ltd (2002–2025)

The table below shows the annual cash flow conversion efficiency of Guizhou Yibai Pharmaceutical Co Ltd from 2002 to 2025. Review 600594 cash flow after capex ratio to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥2.27 Billion ≈ $332.26 Million	CN¥256.71 Million ≈ $37.56 Million	0.113x	+239.16%
2024-12-31	CN¥2.61 Billion ≈ $381.36 Million	CN¥86.87 Million ≈ $12.71 Million	0.033x	-73.36%
2023-12-31	CN¥3.02 Billion ≈ $441.67 Million	CN¥377.61 Million ≈ $55.26 Million	0.125x	+15.58%
2022-12-31	CN¥3.19 Billion ≈ $466.79 Million	CN¥345.30 Million ≈ $50.53 Million	0.108x	-58.72%
2021-12-31	CN¥3.56 Billion ≈ $521.30 Million	CN¥934.21 Million ≈ $136.70 Million	0.262x	+147.69%
2020-12-31	CN¥3.46 Billion ≈ $506.76 Million	CN¥366.66 Million ≈ $53.65 Million	0.106x	+8.67%
2019-12-31	CN¥3.72 Billion ≈ $544.80 Million	CN¥362.71 Million ≈ $53.08 Million	0.097x	+77.78%
2018-12-31	CN¥3.91 Billion ≈ $572.24 Million	CN¥214.30 Million ≈ $31.36 Million	0.055x	-62.69%
2017-12-31	CN¥4.64 Billion ≈ $679.20 Million	CN¥681.78 Million ≈ $99.77 Million	0.147x	+61.80%
2016-12-31	CN¥4.19 Billion ≈ $613.53 Million	CN¥380.62 Million ≈ $55.70 Million	0.091x	-43.82%
2015-12-31	CN¥3.55 Billion ≈ $519.48 Million	CN¥573.68 Million ≈ $83.95 Million	0.162x	+2.18%
2014-12-31	CN¥3.42 Billion ≈ $501.09 Million	CN¥541.58 Million ≈ $79.25 Million	0.158x	-47.05%
2013-12-31	CN¥1.93 Billion ≈ $282.78 Million	CN¥577.24 Million ≈ $84.47 Million	0.299x	+60.29%
2012-12-31	CN¥1.55 Billion ≈ $226.16 Million	CN¥288.01 Million ≈ $42.15 Million	0.186x	-23.66%
2011-12-31	CN¥1.14 Billion ≈ $166.55 Million	CN¥277.83 Million ≈ $40.65 Million	0.244x	+84.89%
2010-12-31	CN¥876.05 Million ≈ $128.19 Million	CN¥115.66 Million ≈ $16.92 Million	0.132x	-9.65%
2009-12-31	CN¥710.95 Million ≈ $104.03 Million	CN¥103.88 Million ≈ $15.20 Million	0.146x	-53.82%
2008-12-31	CN¥598.16 Million ≈ $87.53 Million	CN¥189.26 Million ≈ $27.69 Million	0.316x	+1304.16%
2007-12-31	CN¥530.04 Million ≈ $77.56 Million	CN¥11.94 Million ≈ $1.75 Million	0.023x	-89.98%
2006-12-31	CN¥425.69 Million ≈ $62.29 Million	CN¥95.77 Million ≈ $14.01 Million	0.225x	+608.46%
2005-12-31	CN¥547.39 Million ≈ $80.10 Million	CN¥17.38 Million ≈ $2.54 Million	0.032x	+135.92%
2004-12-31	CN¥506.70 Million ≈ $74.15 Million	CN¥-44.80 Million ≈ $-6.56 Million	-0.088x	-117.30%
2003-12-31	CN¥180.22 Million ≈ $26.37 Million	CN¥92.10 Million ≈ $13.48 Million	0.511x	-10.81%
2002-12-31	CN¥128.20 Million ≈ $18.76 Million	CN¥73.46 Million ≈ $10.75 Million	0.573x	--

About Guizhou Yibai Pharmaceutical Co Ltd

SHG:600594 China Drug Manufacturers - Specialty & Generic

Market Cap

$369.67 Million

CN¥2.53 Billion CNY

Market Cap Rank

#13480 Global

#3928 in China

Share Price

CN¥3.19

Change (1 day)

+0.00%

52-Week Range

CN¥2.95 - CN¥5.06

All Time High

CN¥19.64